By: Tanya Thomas on July 12, 2010 at 10:39 AM Vaccine manufacturers in India and other developing nations can produce a lower-cost HPV vaccine despite the complicated array of patent protections on the technology, according to an Indian-origin scientist at the Duke Institute for Genome Sciences and Policy. At a cost of at least 300dollars […]
Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India
This study has been suspended. (Temporarily suspended: waiting for Indian Governement clearance ) Official Title Randomised Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India Purpose The primary study hypothesis is that a two-dose human papillomavirus (HPV) vaccine regimen would offer similar immunogenicity and protection as that of a three-dose regimen […]
- « Previous Page
- 1
- …
- 7
- 8
- 9
